The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $4.46 in the prior trading day, Altimmune Inc (NASDAQ: ALT) closed at $4.24, down -4.93%. In other words, the price has decreased by -$4.93 from its previous closing price. On the day, 2.98 million shares were traded. ALT stock price reached its highest trading level at $4.4385 during the session, while it also had its lowest trading level at $4.13.
Ratios:
Our goal is to gain a better understanding of ALT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.10 and its Current Ratio is at 13.10. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.
On November 12, 2024, UBS started tracking the stock assigning a Buy rating and target price of $26.UBS initiated its Buy rating on November 12, 2024, with a $26 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share. On Aug 19 ’24, another insider, Drutz David, who serves as the Director of the company, sold 16,011 shares for $6.90 each. As a result, the insider received 110,547 and left with 41,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 326538048 and an Enterprise Value of 196327904. For the stock, the TTM Price-to-Sale (P/S) ratio is 16327.00 while its Price-to-Book (P/B) ratio in mrq is 2.48. Its current Enterprise Value per Revenue stands at 9816.395 whereas that against EBITDA is -1.907.
Stock Price History:
The Beta on a monthly basis for ALT is 1.17, which has changed by -0.5075494 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $11.16, while it has fallen to a 52-week low of $4.43. The 50-Day Moving Average of the stock is -29.58%, while the 200-Day Moving Average is calculated to be -38.23%.
Shares Statistics:
The stock has traded on average 2.52M shares per day over the past 3-months and 2211780 shares per day over the last 10 days, according to various share statistics. A total of 77.01M shares are outstanding, with a floating share count of 76.21M. Insiders hold about 1.04% of the company’s shares, while institutions hold 53.13% stake in the company. Shares short for ALT as of 1741910400 were 22452019 with a Short Ratio of 8.93, compared to 1739491200 on 22472098. Therefore, it implies a Short% of Shares Outstanding of 22452019 and a Short% of Float of 29.389998000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
